| Your Source for the Latest Patent Information |
User Functions Categories- All
- Announcements (5)
- In The News (609)
- OG Notice Links (306)
- Patents of the Day (468)
Archives- December 2007 (18)
- November 2007 (36)
- October 2007 (45)
- September 2007 (36)
- August 2007 (36)
- July 2007 (44)
- June 2007 (36)
- May 2007 (45)
- April 2007 (36)
- March 2007 (36)
- February 2007 (39)
- January 2007 (44)
- more...
Search Syndication Credits- powered by b2evo
- skin cloned from Movable Type
|
GEN-ERIC Patent News
Your Source for the Latest Patent Information
04/26/05
6,883,462 Doggie poop freeze wand  04/26/05
6,885,738 Activation of electronic lock using telecommunications network  04/26/05
6,885,304 Monitoring of crowd response to performances  04/26/05
Medtronic Inc. ended a long-running patent fight Friday by agreeing to pay $1.35 billion to a Los Angeles doctor who invented much of its spinal-treatment technology. The settlement with Dr. Gary K. Michelson and his company, Karlin Technology, calls for Medtronic to pay $800 million to buy spinal-fusion technology and $550 million to settle the legal claims. Michelson had sought $1.7 billion when he sued Medtronic, and a jury awarded him about $510 million in punitive and compensatory damages last fall, saying Medtronic broke agreements that cover an implant used to treat damaged or diseased spinal discs. He had claimed Medtronic breached patent agreements he made with spinal implant maker Sofamor Danek a decade ago before it was acquired by Medtronic in 1999. Posted by GEN-ERIC at 12:20:45 am into the following categories: In The News04/26/05
Dolby Laboratories Inc. has announced it has received a favorable from that the U.S. District Court for the Northern District of California stating the company did not infringe on two patents belonging Lucent Technologies Inc. relating to Dolby compression technology. The Court concurred with a request by Dolby (San Francisco, Calif.) for a summary judgement the company did not infringe on U.S. Patent Nos. 5,627,938 and 5,341,457. Lucent alleged that Dolby's AC-3 audio compression technology required licenses to use these patents. Dolby originally filed a lawsuit against Lucent in May 2001 claiming the patents are invalid. In August 2002, Lucent filed a counterclaim alleging Dolby directly infringed on both patents and induced others to also infringe upon the patents. Posted by GEN-ERIC at 12:19:28 am into the following categories: In The News04/26/05
Microsoft Corp. faces a patent infringement claim from a small Texas company over technology that's used in JPEG files, one of the most common image formats. Forgent Networks Inc. of Austin filed suit in the U.S. District Court for Eastern Texas, said Michael Noonan, director of investor relations at Forgent. The patent, which expires in October next year, was granted in 1987 to Forgent unit Compression Labs Inc., Noonan said. Microsoft earlier this month filed for a declaratory judgment for non-infringement. Posted by GEN-ERIC at 12:17:55 am into the following categories: In The News04/26/05
German drugmaker Altana has filed a lawsuit against India's Sun Pharmaceutical Industries alleging patent infringement on Altana's top drug, anti-ulcer treatment pantoprazole, it said on Friday. An Altana spokesman said that the company and its U.S. partner Wyeth had filed the lawsuit against Sun in a New Jersey court. The lawsuit was in response to Sun's so-called paragraph IV generic application in the United States, seeking approval for a copycat version of Protonix, the brand name under which Wyeth sells pantoprazole in the United States. A generic application with a paragraph IV certification means that the applicant is claiming that a patent is invalid or not challenged by its product. Posted by GEN-ERIC at 12:16:27 am into the following categories: In The News04/19/05
6,881,123 Natural shape enhancing brassiere  04/19/05
6,860,466 Sub-lethal, wireless projectile and accessories  04/19/05
6,882,285 PDA watch  04/19/05
Microsoft might have to delay shipment of an upgrade to Windows Server 2003 and the company's next major operating system, Longhorn, as a result of an injunction made by a U.S. District Court in response to claims by Alacritech, a start-up company, that Microsoft appropriated its technology without a license. The preliminary ruling prevents Microsoft from using its TCP offload architecture -- code-named Chimney -- that it has included in its Windows Server 2003 and Longhorn. According to Alacritech, it met with Microsoft in 1998 and described its architecture in detail under a nondisclosure agreement. In April 1999, it delivered to Microsoft a detailed architecture document for integrating SLIC technology into the Windows operating system. In June, Alacritech said, Microsoft cut off communication with the firm. "After Alacritech discovered that Microsoft Chimney is based on intellectual property that we developed, patented and own, we offered Microsoft a license," said Larry Boucher, president and CEO, Alacritech. "Microsoft rejected licensing terms that would be acceptable to us." The company then sued Microsoft in Federal District Court in August 11, 2004, alleging that Chimney is based on technology that it began patenting in 1997. Microsoft has claimed that it developed Chimney independently. Posted by GEN-ERIC at 12:08:01 am into the following categories: In The News04/19/05
Competitive Technologies, Inc. announced today the receipt of $1.15 million from their homocysteine assay patent infringement case against Laboratory Corporation of America Holdings (LabCorp). CTT's share of the payment is approximately $230,000. The funds represent a payment against attorney's fees, court costs and post-judgment interest awarded to CTT and its clients. In June 2004 the US Court of Appeals for the Federal Circuit affirmed the CDC's November 2002 decision upholding the validity of the patent. CTT has successfully signed license agreements and is collecting royalties from companies performing the majority of homocysteine assays in the marketplace. These companies include Bayer, Abbott, Roche, Quest, Diagnostic Products and GENCHEM. CTT has an active program of collecting previously withheld royalties from all organizations involved in the homocysteine assay process. The assay patent is derived from discoveries made by CTT's clients, Drs. Robert Allen and Sally Stabler from the University of Colorado and the late Dr. John Lindenbaum from Columbia University. Posted by GEN-ERIC at 12:05:57 am into the following categories: In The News04/19/05
Dr Reddy’s Laboratories (DRL) has lost a key patents case against drug major Eli Lilly & Company. A US district court upheld the patent validity of Zyprexa, Lilly’s blockbuster drug to treat schizophrenia. DRL, along with Ivax Corp and Teva Pharmaceuticals, failed to convince Judge Richard Young that they had strong evidence of the patent’s validity. The decision arose from a May 2001 suit by Eli Lilly against these companies. Had DRL been successful, it would have resulted in the company making a generic version of the drug. DRL had earlier won a patent lawsuit involving Lilly. This case, concerning anti-depressant Prozac, brought the company a windfall of $60 million. DRL has now decided to appeal against today’s decision in a higher court. “We are disappointed by the order and will appeal against it to the Federal Circuit. Despite the adverse ruling, our strategy remains unchanged and we continue to make consistent progress towards building a sustainable generics business in the US,” DRL chief executive G. V. Prasad said. Posted by GEN-ERIC at 12:04:42 am into the following categories: In The News04/12/05
6,879,990 System for identifying potential licensees of a source patent portfolio  04/12/05
6,879,242 Color based lock and key  04/12/05
6,879,945 System and method for sizing footwear over a computer network  04/12/05
A federal Bankruptcy Court hit Weyerhaeuser Co. yesterday with a nearly $461 million judgment in connection with a disposable-diaper business that the forest products company unloaded more than a decade ago. Federal Way-based Weyerhaeuser said it plans to appeal the decision, issued by a judge in a federal court for the Northern District of Georgia. While the verdict is more than double the $199 million after-tax profit that Weyerhaeuser reported for the fourth quarter, the company said it hasn't set aside any money to cover the judgment because it believes the decision will be reversed and there is a "high likelihood" it won't be required to pay the award. The Bankruptcy Court case concerns Paragon Trade Brands, a maker of private-label disposable diapers (sold by grocery stores and other retailers under their own brand names) that Weyerhaeuser spun off as a publicly traded company in the early 1990s. Rival diaper manufacturers Kimberly-Clark and Procter & Gamble filed patent infringement suits against Paragon because of certain design features of its products. Weyerhaeuser says the two companies had made the allegations before the Paragon spinoff but it rejected the claims. Posted by GEN-ERIC at 12:15:26 am into the following categories: In The News04/12/05
Microsoft Corp. said it will pay Gateway Inc. $150 million over four years to settle the companies' antitrust dispute. Redmond-based Microsoft (NASDAQ: MSFT) and Irvine, Calif.-based Gateway (NYSE: GTW) now plan to work together "on the marketing and development of Gateway personal computing products," according to an announcement. "Our relationships with PC manufacturers are integral to our success, and we look forward to working even more closely with Gateway to communicate the benefits of its products and our software to consumers," Rodrigo Costa, Microsoft's OEM corporate vice president, said in a statement. Gateway was specifically identified in the antitrust suit brought against Microsoft in the mid-1990s as a company that was harmed by Microsoft's business tactics. Posted by GEN-ERIC at 12:14:09 am into the following categories: In The News04/12/05
Finisar Corporation (NASDAQ: FNSR) announced today that it has filed a patent infringement lawsuit against The DirecTV Group, Inc. and related entities (DirecTV) in the U.S. District Court for the Eastern District of Texas, located in Beaumont, Texas. The suit alleges that DirecTV has engaged in and continues to engage in willful infringement of Finisar's U.S. Patent No. 5,404,505 (the '505 patent) directed to an information transmission system. The '505 patent was invented by Finisar's Chief Technology Officer and co-founder, Dr. Frank Levinson. Finisar is seeking monetary damages from DirecTV as well as injunctive relief. The lawsuit states that Finisar repeatedly contacted DirecTV about its infringement of the '505 patent throughout 2004 and early 2005, indicating its willingness to engage DirecTV in licensing discussions, but Finisar's requests to begin a dialog on the matter were not successful. "While we are not a litigious company, we have not been able to make any meaningful progress in resolving this infringement by any other means," said Steve Workman, Finisar's Chief Financial Officer. "We obviously believe that we have strong grounds for taking this action and that our patent will ultimately be enforced in this case." Posted by GEN-ERIC at 12:12:44 am into the following categories: In The News04/12/05
Forgent Networks, which has so far garnered more than $100 million in fees on its so-called JPEG patent, is going after the digital video recorder industry. The Austin, Texas-based maker of licensing and scheduling software owns four patents it claims give it the right to collect royalties on computers or similar devices, such as those made by market leader TiVo, that record, store and play back video- and audio-transmitted signals. While three of the patents primarily involve videoconferencing systems, patent No. 6,674,960 specifically addresses recording television signals to a computer. The patents also predate patents and other intellectual property owned by other companies, Forgent Chief Financial Officer Jay Peterson said in an interview. "You'll see activity on the DVR (digital video recorder) patents in the next three to nine months," he said. "We've got an early file date." Posted by GEN-ERIC at 12:11:29 am into the following categories: In The News04/05/05
6,874,180 Rug bed cloth structure for assisting in holding a user's legs in a fixed position  04/05/05
6,876,997 Method and apparatus for identifying related searches in a database search system  04/05/05
6,875,909 92 key piano  04/05/05
Investors knocked more than 20 per cent off the shares of MOSAID Technologies during early trading Monday, after the company reported a setback in its patent infringement lawsuit against Infineon Technologies. In a summary decision, a court in New Jersey ruled that Infineon's accused products do not infringe on six MOSAID patents. The court did not issue a ruling on a seventh patent claim. The court also moved to limit MOSAID's potential for collecting damages, by ruling that the company can only seek damages for the period prior to filing the lawsuit for products that were specifically identified in the letters notifying Infineon of infringement. MOSAID executives admit they were taken by surprise by the ruling. Posted by GEN-ERIC at 12:47:31 am into the following categories: In The News04/05/05
Broadwing Communications, which changed its name from Corvis last year, has agreed to pay Ciena $35 million to settle a five year old patent infringement lawsuit. Linthicum-based Ciena (NASDAQ: CIEN), which makes fiber optic equipment, filed a suit against Corvis, based in Columbia, in 2000. A jury sided with Ciena and a judge ordered Corvis to stop selling products that infringed on two Ciena patents. Corvis later appealed. The settlement ends a long court fight between two companies that were once rivals but now do business with each other. In fact, terms of the settlement allow for Broadwing to use up to $33 million of the settlement as credits toward Ciena equipment and services. Posted by GEN-ERIC at 12:42:28 am into the following categories: In The News04/05/05
A U.S. court has ordered MJ Research, a division of Bio-Rad Laboratories Inc., to pay an additional $15 million in damages to competitors Roche Molecular Systems and Applied Biosystems for infringing on patents. The decision brings the total amount MJ Research must pay to about $35 million. The ruling comes a year after a jury concluded that MJ Research "willfully" infringed patents related to polymerase chain reaction and awarded $19.8 million in damages, Applied Biosystems said Monday. The U.S. District Court in New Haven, Conn. also dismissed all of MJ Research's antitrust counterclaims against Applied and Roche. Posted by GEN-ERIC at 12:41:09 am into the following categories: In The News
|
Calendar| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | |
LinksEmployment
USPTO
